Embattled businessman Vijay Mallya is quitting as the chairman of Bayer CropScience Ltd after over 12 years of holding the position in the company.
Mallya, who was appointed as the chairman of the Board in March 2004, will cease to be the chairman and Director with effect from June 30, Bayer CropScience said in a statement.
Commenting on the development, the company said: “Bayer CropScience Ltd regretfully accepts the voluntary resignation of Vijay Mallya as its Director and chairman.”
- ED likely to move court to liquidate Vijay Mallya’s assets
- Vijay Mallya can be regarded as ‘fugitive from justice’: UK HC
- Vijay Mallya extradition trial: CBI gets boost on evidence admissibility, next hearing on July 11
- Vijay Mallya takes Rs 1.7 cr pay package from US brewery firm
- Vijay Mallya exits from Sanofi after 33 years as chairman
- Sanofi, Bayer have Mallya as chairman, in India
The company said it will appoint a new chairman at the next board meeting.
Mallya, who is currently wanted in India over loan default cases related to the long-defunct Kingfisher Airlines, had in March announced retirement from the post of chairman of Sanofi India.
In March, he had left the country amid continuing efforts by banks to recover dues totaling over Rs 9,000 crore of unpaid loans and interest owed by Kingfisher Airlines.
He had agreed to quit as the chairman of United Spirits Ltd in February after its new majority owner Diageo agreed to pay him Rs 515 crore and absolve him of all liabilities over alleged financial lapses at the company founded by his family.
On reasons for his move, Mallya had said that he wanted to spend more time in England closer to his children.
Bayer is a global enterprise with core competencies in the life science fields of healthcare and agriculture. In India, Bayer CropScience is into seed and crop protection business.